drugset
drugset / Trial / NCT03653364

Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms

NCT03653364 ↗

Phase 3 Completed 49 enrolled Hoffmann-La Roche
NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the safety, pharmacokinetics and efficacy of baloxavir marboxil in healthy pediatric participants from birth to \<1 year with influenza like symptoms

Timeline

Start
2019-01-23
Primary completion
2023-04-03
Completion
2023-04-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Baloxavir Marboxil Unknown 1 mg/kg Oral
Subject Baloxavir Marboxil Unknown 2 mg/kg Oral

Indications

influenza